Facility Evaluation Report

Licensing Program Analyst (LPA) Christine Yee conducted an unannounced case management visit due to deficiencies noted during a complaint visit to the facility today. The reason for today's visit was explained.

During the visit to the facility today, LPA Yee conducted file review of residents' files and medications.

Per the file and medication review, LPA Yee observed that the Resident #1 is prescribed Quetiapine Fumarate (Seroquel) 25 milligram tablet as a PRN every 4 hours as needed. LPA Yee did not observe any PRN Authorization Letter in the resident's file.

Deficiencies cited under California Code of Regulations, Title 22, Division 6, Chapter 8

Exit interview was conducted, Appeals Rights discussed and a copy was provided.